<DOC>
	<DOCNO>NCT02141516</DOCNO>
	<brief_summary>The study aim evaluate safety immunogenicity rMenB+OMV NZ administer subject 2 17 year age increase risk meningococcal disease either primary secondary complement deficiency asplenia splenic dysfunction . A group healthy age-matched subject enrol serve descriptive control immunogenicity safety .</brief_summary>
	<brief_title>Safety Immunogenicity Novartis Meningococcal B Vaccine When Administered Immunocompromised Children Adolescents Compared Healthy Subjects .</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Complement System Proteins</mesh_term>
	<criteria>Inclusion criterion applicable All Groups Subjects age 2 17 year ( inclusive ) enrollment weigh least 13 Kg time enrollment Inclusion criterion applicable Group A Subjects risk meningococcal disease primary secondary complement deficiency Inclusion criterion applicable Group B Subjects risk meningococcal disease functional anatomic asplenia Inclusion criterion applicable Group C healthy subject Exclusion criterion applicable All Groups ( A , B C ) History previous immunization meningococcal B vaccine History severe allergic reaction previous vaccination , hypersensitivity component vaccine Known HIV infection History progressive severe neurologic disorder seizure disorder Contraindication intramuscular injection blood drawn Females pregnant , plan pregnancy nursing ( breastfeed ) Females childbearing potential use plan use acceptable birth control measure History illness/condition , opinion investigator , might interfere result study pose additional risk subject Exclusion criterion applicable Groups A B Previous know suspected disease cause N. meningitidis last year . Exclusion criterion applicable Group C Previous know suspected disease cause N. meningitidis Known suspect impairment/alteration immune system</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Meningitis</keyword>
	<keyword>vaccination</keyword>
	<keyword>complement deficiency</keyword>
	<keyword>asplenia</keyword>
	<keyword>splenic dysfunction</keyword>
</DOC>